Delivery Order SPE2DB24D2011-SPE2DB24FBQTB

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,295.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of October 11, 2024 and is a firm-fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,460.12 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGE syringes. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle...
This federal contract award, valued at $10,381.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of November 19, 2024 and a fixed-price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $6,739.10, is for the delivery of STELARA 90 MG/ML syringes. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $93,327.88 Firm Fixed Price delivery order is for the supply of STELARA 90 MG/ML syringes, with a completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $33,188.36 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication, with a period of performance through November 27, 2024. This award is under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,738.06 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes, a specialty medication. The contract has an ultimate completion date of December 19, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,091.42 Firm Fixed Price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical medication. The contract has an ultimate completion date of November 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $17,662.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of STELARA 90 MG/ML SYRINGE/ML, a specialty medication. The contract has an ultimate completion date of January 24, 2025 and is a Firm Fixed Price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The fixed-price delivery order, valued at $15,038.71, has a completion date of May 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBQTB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of STELARA 90 MG/ML SYRINGE medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This $38,475.01 firm fixed price contract has an ultimate completion date of August 5, 2024 and does not utilize a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain to provide critical medications and medical commodities to various federal agencies and healthcare programs.

Generated 11/1/24, 9:32 AM